NCT04489836 (GlutDigestP) is a NA clinical trial of Glutalytic® in Main Focus: Gluten and Starch Digestibility, sponsored by Deerland Enzymes.

Who is sponsoring NCT04489836?

NCT04489836 is sponsored by Deerland Enzymes.

What drugs are being tested in NCT04489836?

Interventions in NCT04489836: Glutalytic®, DE111®, Meal A.

What condition does NCT04489836 study?

NCT04489836 studies Main Focus: Gluten and Starch Digestibility.

Is NCT04489836 still recruiting?

NCT04489836 is currently completed. Last updated 23 October 2020.

Last reviewed 2020-10-23 · How we verify

NCT04489836: GlutDigestP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

GlutDigest - Pilot Study

Completed NA Last updated 23 October 2020

What this trial tests

NA trial testing Glutalytic® in Main Focus: Gluten and Starch Digestibility in 2 participants. Completed in 19 September 2020.

Timeline

31 August 2020

Primary endpoint
19 September 2020

19 September 2020

Quick facts

Lead sponsor	Deerland Enzymes
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	2
Start date	31 August 2020
Primary completion	19 September 2020
Estimated completion	19 September 2020
Sites	1 location across Ireland

Drugs / interventions tested

Glutalytic®
DE111®
Meal A

Conditions studied

Main Focus: Gluten and Starch Digestibility — all drugs for Main Focus: Gluten and Starch Digestibility →

Sponsor

Deerland Enzymes

Who can join

Adults 18 to 75, any sex, with Main Focus: Gluten and Starch Digestibility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a pilot, feasibility study to evaluate, test and optimize sample analysis procedures and protocols before the full-scale, crossover study is conducted.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Deerland Enzymes trials

Trials by the same sponsor.

NCT04917913 — Efficacy of a Digestive Enzyme Blend · NA · unknown
NCT04144777 — Efficacy of Solarplast for Health and Oxidative Stress · NA · completed
NCT04077034 — Effect of Probiotic Formula DE111® on Immune System in Preschool Children · NA · completed
NCT04144114 — The Effect of ProHydrolase® on the Amino Acid, Intramuscular Anabolic Signaling, and Endocrine Response to Resistance Ex · NA · completed
NCT04083521 — Effect of Bacillus Subtilis DE111® on Daily Bowel Movements · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04489836 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Deerland Enzymes
Last refreshed: 23 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04489836.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing